Karyopharm Therapeutics News

Karyopharm Therapeutics | 8-K: Current report

May 14 16:10 ET

Karyopharm Therapeutics | 8-K: Current report

May 8 07:53 ET

Karyopharm Therapeutics | 8-K: Current report

May 8 07:53 ET

Karyopharm Therapeutics | DEFA14A: Others

Apr 19 07:48 ET

Karyopharm Therapeutics | DEF 14A: Definitive information statements

Apr 19 07:38 ET

Karyopharm Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 8 16:43 ET

Karyopharm Therapeutics | 8-K: Current report

Feb 29 07:38 ET

Karyopharm Therapeutics | 8-K: Current report

Feb 20 08:03 ET

Karyopharm Therapeutics | 8-K: Current report

Jan 8 00:00 ET

Karyopharm Therapeutics | 8-K: Current report

Dec 12, 2023 16:05 ET

Karyopharm Therapeutics | 8-K: Current report

Dec 8, 2023 08:00 ET

Karyopharm Therapeutics | 8-K: Current report

Nov 2, 2023 07:37 ET

Karyopharm Therapeutics | 8-K: Current report

Sep 1, 2023 08:06 ET

Karyopharm Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 2, 2023 08:59 ET

Karyopharm Therapeutics | 8-K: Current report

Aug 2, 2023 07:37 ET

Karyopharm Therapeutics | 8-K: Current report

May 25, 2023 16:02 ET

Karyopharm Therapeutics | 8-K: Current report

May 4, 2023 07:53 ET

Karyopharm Therapeutics | DEFA14A: Others

Apr 11, 2023 08:11 ET

Karyopharm Therapeutics | DEF 14A: Definitive proxy statements

Apr 11, 2023 08:02 ET

Karyopharm Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Mar 31, 2023 16:12 ET